- Home
- ICUI vs RELY Comparison
ICUI vs RELY Comparison
Compare ICUI & RELY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- RELY
- Stock Information
- Founded
- ICUI 1984
- RELY 2011
- Country
- ICUI United States
- RELY United States
- Employees
- ICUI N/A
- RELY N/A
- Industry
- ICUI Medical/Dental Instruments
- RELY Computer Software: Prepackaged Software
- Sector
- ICUI Health Care
- RELY Technology
- Exchange
- ICUI Nasdaq
- RELY Nasdaq
- Market Cap
- ICUI 3.4B
- RELY 3.5B
- IPO Year
- ICUI 1992
- RELY 2021
- Fundamental
- Price
- ICUI $127.40
- RELY $15.79
- Analyst Decision
- ICUI Strong Buy
- RELY Buy
- Analyst Count
- ICUI 5
- RELY 10
- Target Price
- ICUI $196.75
- RELY $27.40
- AVG Volume (30 Days)
- ICUI 186.2K
- RELY 3.8M
- Earning Date
- ICUI 08-07-2025
- RELY 08-06-2025
- Dividend Yield
- ICUI N/A
- RELY N/A
- EPS Growth
- ICUI N/A
- RELY N/A
- EPS
- ICUI N/A
- RELY N/A
- Revenue
- ICUI $2,420,093,000.00
- RELY $1,356,469,000.00
- Revenue This Year
- ICUI N/A
- RELY $27.85
- Revenue Next Year
- ICUI N/A
- RELY $20.30
- P/E Ratio
- ICUI N/A
- RELY N/A
- Revenue Growth
- ICUI 7.22
- RELY 34.37
- 52 Week Low
- ICUI $117.92
- RELY $12.43
- 52 Week High
- ICUI $196.26
- RELY $27.32
- Technical
- Relative Strength Index (RSI)
- ICUI 46.81
- RELY 24.80
- Support Level
- ICUI $124.39
- RELY $16.86
- Resistance Level
- ICUI $134.04
- RELY $17.15
- Average True Range (ATR)
- ICUI 3.75
- RELY 0.50
- MACD
- ICUI 0.18
- RELY -0.02
- Stochastic Oscillator
- ICUI 47.55
- RELY 7.98
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About RELY Remitly Global Inc.
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.